ONESOURCE SPECL PHARMA L (ONESOURCE) Share Price Rises 5.29% Today

ONESOURCE Share Price rose 5.29% to Rs 1,634.45, lifting the company’s market capitalisation to Rs 17,587.38 Cr. Latest Univest figures confirm a same-day price rise, but they do not establish a company-specific catalyst. In Stock Market Today terms, the move places ONESOURCE among the Stocks in News and Top Gainers Today, with turnover at Rs 2.64 Cr adding context to the trading day.

ONESOURCE Share Price is trading higher today, with ONESOURCE Share Price Today at Rs 1,634.45 after a gain of 5.29% from the previous close of Rs 1,552.40. The move added Rs 82.05 to the stock and pushed the company’s market cap to Rs 17,587.38 Cr. The latest Univest figures confirm the price event, while the record does not establish a company-specific catalyst behind the rise.

ONESOURCE Share Price Today: Price Action Analysis

For readers tracking ONESOURCE Stock News, the key point is that the share price rise happened in a live market setting and not as a standalone valuation event. ONESOURCE Share Price Live action now needs to be read alongside the company’s premium-to-median valuation, negative ROE, modest ROCE and large-cap profile in the pharmaceuticals space. That combination makes ONESOURCE Stock Gaining Today relevant for both price-action followers and fundamental watchers. Univest is following the move as part of broader Market News and Indian Stock Market coverage.

Metric	Value
Current Price	Rs 1,634.45
Previous Close	Rs 1,552.4
Today's Move	Rs 82.05 (+5.29%)
Open	Rs 1,575
High	Rs 1,636
Low	Rs 1,575
Turnover	Rs 2.64 crore
Market Capitalisation	Rs 17,587.38 crore
Market Cap Category	Mid Cap

ONESOURCE SPECL PHARMA L (ONESOURCE) rose to Rs 1,634.45 from the previous close of Rs 1,552.4, a move of Rs 82.05 or 5.29%. The stock opened at Rs 1,575, reached a high of Rs 1,636, recorded a low of Rs 1,575.

ONESOURCE Share Price Today opened at Rs 1,575.00, moved between Rs 1,575.00 and Rs 1,636.00, and last traded at Rs 1,634.45. The stock is trading above the previous close by Rs 82.05, which equals 5.29% for the day. This is a clear price rise rather than a late-session statistical adjustment, and it places ONESOURCE in focus among Stocks Rising Today. The trading range also shows that the stock held firm after opening and remained near the day’s upper end.

ONESOURCE SPECL PHARMA L (ONESOURCE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 17,587.38 crore
P/B Ratio	3.04x
ROE	-1.26%
ROCE	0.44%
EPS	Rs -4.24
Book Value Per Share	Rs 510.17
Dividend Yield	0%

ONESOURCE SPECL PHARMA L (ONESOURCE) fundamental metrics show P/B 3.04x, ROE -1.26%, ROCE 0.44%. These figures provide context only and are not a buy or sell signal.

ONESOURCE SPECL PHARMA L has a market capitalisation of Rs 17587.38 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 3.04x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -1.26% and ROCE of 0.44%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -4.24, book value per share of Rs 510.17, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.52x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	32.52x
Benchmark Average P/E	49x
Benchmark P/E Range	3.35x to 654.07x
Company P/B Ratio	3.04x
Benchmark Median P/B	3x
Company ROE	-1.26%
Benchmark Median ROE	11.82%
Company ROCE	0.44%
Benchmark Median ROCE	13.71%
Company Market Capitalisation	Rs 17,587.38 crore
Benchmark Median Market Cap	Rs 701.65 crore

ONESOURCE SPECL PHARMA L (ONESOURCE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

ONESOURCE SPECL PHARMA L (ONESOURCE) has a ROE of -1.26%, which is below the benchmark median of 11.82%, a difference of -110.66%. ONESOURCE SPECL PHARMA L (ONESOURCE) has a ROCE of 0.44%, which is below the benchmark median of 13.71%, a difference of -96.79%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.69	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	84.45	13.99	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	85.68	20.82	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.46	3.21	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	25.53	4.27	19.69	21.39

Its ROE of -1.26% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 0.44% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. ONESOURCE SPECL PHARMA L (ONESOURCE) has a market capitalisation of Rs 17,587.38 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching ONESOURCE

• ONESOURCE Share Price rose 5.29% today, keeping the stock in the spotlight among market movers.
• The move came with Rs 17,587.38 Cr market capitalisation, which places the company well above the industry median.
• ONESOURCE Fundamental Analysis shows P/B at 3.04, close to the industry median and below the industry average.
• ROE of -1.26% and ROCE of 0.44% keep the earnings quality debate relevant for investors tracking the stock.
• The pharmaceuticals peer set gives ONESOURCE Share Price Today a useful comparison point versus larger names such as Sun Pharma and Divi’s Labs.

About ONESOURCE

ONESOURCE SPECL PHARMA L operates in the Healthcare sector and belongs to Pharmaceuticals & Drugs. The company’s listed profile shows a business positioned within the Indian pharmaceutical universe, where investors often compare scale, valuation and return ratios across branded pharma, formulations and related drug businesses. ONESOURCE Share Price reflects how the market values that position today.

The company’s current market capitalisation of Rs 17,587.38 Cr suggests a sizeable listed presence. Its book value of Rs 510.17 per share provides a base for assessing equity backing, while EPS of -4.24 and ROE of -1.26% highlight that the latest financial read-through is not straightforwardly strong. Dividend yield is 0, so the stock is not carrying a payout angle in the current data set. For readers following ONESOURCE Stock Performance, the business profile matters because pharma names are often judged by valuation, margin quality and balance-sheet strength rather than price alone. Univest keeps ONESOURCE Share Price in context with the broader company overview and sector view.

Frequently Asked Questions

Why is ONESOURCE Share Price rising today?

Ans. ONESOURCE Share Price rose 5.29% to Rs 1,634.45. The latest Univest figures confirm the move, but they do not establish a company-specific catalyst, so the event should be read as verified price action.

What is ONESOURCE Share Price Today?

Ans. ONESOURCE Share Price Today is Rs 1,634.45, compared with the previous close of Rs 1,552.40. The stock added Rs 82.05 during the day, which puts it in focus among Stocks Rising Today.

What does ONESOURCE Market Cap show?

Ans. ONESOURCE has a market capitalisation of Rs 17,587.38 Cr. That places it well above the industry median in Pharmaceuticals & Drugs and indicates a large listed company, though size alone does not indicate quality.

Is ONESOURCE expensive on valuation?

Ans. ONESOURCE trades at a P/B of 3.04, which is close to the industry median of 3 and below the industry average of 4.41. That positions the stock near the middle of the peer range on book value.

How do ONESOURCE profits look in the latest fundamental picture?

Ans. ONESOURCE reports EPS of -4.24, ROE of -1.26% and ROCE of 0.44%. Those figures suggest that profitability and capital efficiency remain weaker than the same-industry medians shown in the latest Univest data.

Does ONESOURCE pay a dividend?

Ans. ONESOURCE has a dividend yield of 0. That means the current profile does not show a payout contribution, so investors are instead looking at price action, valuation and operating performance.

How does ONESOURCE compare with pharma peers?

Ans. ONESOURCE’s P/B is below names like Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals, while its ROE and ROCE are weaker than most listed peers. The comparison makes today’s share price move easier to contextualise.

Should investors track ONESOURCE Share Price on Univest?

Ans. Yes. Univest tracks ONESOURCE Share Price with live market context, valuation ratios, sector comparison and company overview. That helps investors follow the stock without relying only on the day’s price rise.

Track ONESOURCE Share Price on Univest

Use ONESOURCE SPECL PHARMA L (ONESOURCE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track ONESOURCE Share Price on Univest for live share price movement, fundamental ratios, valuation context, sector comparison and market insights. Univest also helps readers monitor ONESOURCE Share Price Today alongside stock news, stock analysis and company updates in one place.